...
首页> 外文期刊>Journal of cellular biochemistry. >The RUNX2 Transcription Factor Negatively Regulates SIRT6 Expression to Alter Glucose Metabolism in Breast Cancer Cells
【24h】

The RUNX2 Transcription Factor Negatively Regulates SIRT6 Expression to Alter Glucose Metabolism in Breast Cancer Cells

机译:RUNX2转录因子负调控SIRT6表达,以改变乳腺癌细胞中的葡萄糖代谢。

获取原文
获取原文并翻译 | 示例

摘要

Activation of genes promoting aerobic glycolysis and suppression of mitochondrial oxidative phosphorylation is one of the hallmarks of cancer. The RUNX2 transcription factor mediates breast cancer (BC) metastasis to bone and is regulated by glucose availability. But, the mechanisms by which it regulates glucose metabolism and promotes an oncogenic phenotype are not known. RUNX2 expression in luminal BC cells correlated with lower estrogen receptor- (ER) levels, anchorage-independent growth, expression of glycolytic genes, increased glucose uptake, and sensitivity to glucose starvation, but not to inhibitors of oxidative phosphorylation. Conversely, RUNX2 knockdown in triple-negative BC cells inhibited mammosphere formation and glucose dependence. RUNX2 knockdown resulted in lower LDHA, HK2, and GLUT1 glycolytic gene expression, but upregulation of pyruvate dehydrogenase-A1 (PDHA1) mRNA and enzymatic activity, which was consistent with lower glycolytic potential. The NAD-dependent histone deacetylase, SIRT6, a known tumor suppressor, was a critical regulator of these RUNX2-mediated metabolic changes. RUNX2 expression resulted in elevated pAkt, HK2, and PDHK1 glycolytic protein levels that were reduced by ectopic expression of SIRT6. RUNX2 also repressed mitochondrial oxygen consumption rates (OCR), a measure of oxidative phosphorylation (respiration). Overexpression of SIRT6 increased respiration in RUNX2-positive cells, but knockdown of SIRT6 in cells expressing low RUNX2 decreased respiration. RUNX2 repressed SIRT6 expression at both the transcriptional and post-translational levels and endogenous SIRT6 expression was lower in malignant BC tissues or cell lines that expressed high levels of RUNX2. These results support a hypothesis whereby RUNX2-mediated repression of the SIRT6 tumor suppressor regulates metabolic pathways that promote BC progression. J. Cell. Biochem. 116: 2210-2226, 2015. (c) 2015 Wiley Periodicals, Inc.
机译:促进有氧糖酵解的基因的激活和线粒体氧化磷酸化的抑制是癌症的标志之一。 RUNX2转录因子介导乳腺癌(BC)转移至骨骼,并受葡萄糖利用率的调节。但是,它调节葡萄糖代谢并促进致癌表型的机制尚不清楚。腔BC细胞中RUNX2的表达与较低的雌激素受体(ER)水平,不依赖锚定的生长,糖酵解基因的表达,葡萄糖摄取增加以及对葡萄糖饥饿的敏感性有关,但与氧化磷酸化抑制剂无关。相反,三阴性BC细胞中的RUNX2敲低抑制了乳球形成和葡萄糖依赖性。 RUNX2敲低导致较低的LDHA,HK2和GLUT1糖酵解基因表达,但丙酮酸脱氢酶A1(PDHA1)mRNA和酶活性上调,这与较低的糖酵解潜力相符。 NAD依赖的组蛋白脱乙酰基酶SIRT6是一种已知的肿瘤抑制因子,是这些RUNX2介导的代谢变化的关键调节剂。 RUNX2表达导致升高的pAkt,HK2和PDHK1糖酵解蛋白水平,而SIRT6的异位表达则降低了糖蛋白水平。 RUNX2还抑制线粒体耗氧率(OCR),这是氧化磷酸化(呼吸)的量度。 SIRT6的过表达增加了RUNX2阳性细胞的呼吸,但是在表达低RUNX2的细胞中SIRT6的敲低降低了呼吸。 RUNX2在转录水平和翻译后水平均抑制SIRT6表达,在表达高水平RUNX2的恶性BC组织或细胞系中,内源性SIRT6表达较低。这些结果支持一个假设,在该假设中,RUNX2介导的SIRT6肿瘤抑制因子的阻遏调节了促进BC进展的代谢途径。 J.细胞。生化。 116:2210-2226,2015。(c)2015 Wiley Periodicals,Inc.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号